| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119953 Sickle cell anemia |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/28/2002 | EP1233958A1 Inhibitors of histone deacetylase |
| 08/28/2002 | EP0973731B1 Hydroxamic acid derivatives |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/21/2002 | EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 08/20/2002 | US6436990 Antiinflammatory, rheumatic and antiarthritic agents, having improved transformation; side effect reduction |
| 08/13/2002 | US6433223 Hydroxylamine compound |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6428780 Modified amino acid |
| 07/31/2002 | EP0935669B1 Enzymatic synthesis of optically active hydroxamic acids and their conversion into optically active primary amines by lossen transposition |
| 07/25/2002 | WO2001092273A3 Benzenedicarboxylic acid derivatives |
| 07/24/2002 | EP1224164A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 |
| 07/23/2002 | US6423737 Benzamidoxime prodrugs as antipneumocystic agents |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/23/2002 | US6423676 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/17/2002 | EP1039902A4 Inhibitors of gap junction communication |
| 07/17/2002 | EP0925278B1 Cytostatic hydroxamic acid derivatives |
| 07/16/2002 | US6420605 Difluoromethyl ethers of benzamidoxime compounds |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/11/2002 | WO2002053146A2 Matrix metalloproteinase inhibitors |
| 07/11/2002 | CA2430672A1 Matrix metalloproteinase inhibitors |
| 07/09/2002 | US6417398 Benzamidoxim derivatives, intermediate products and methods for preparing them, and their use as fungicides |
| 07/09/2002 | US6417200 Antithrombotic agents |
| 07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/04/2002 | US20020086877 Matrix metalloproteinase inhibitors |
| 07/03/2002 | EP1218339A2 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 07/03/2002 | CN1356312A Process for synthesizing dihydroxytin mononuclear p-amino-or p-nitro benzoyl hydroxamate match |
| 07/03/2002 | CN1356311A Match of dihydroxytin mononuclear glycyl (or alanyl) hydroxamate and its synthesizing process |
| 07/03/2002 | CN1356310A Match of dihydroxytin binuclear glycyl (or alkyl) hydroxamate and its synthesizing process |
| 07/03/2002 | CN1356309A Match of dihydroxytin monoclear p-chloro, p-fluoro or p-methoxyl-benzoyl hydroxamate and its synthesizing process |
| 07/02/2002 | US6414122 Biochemical conjugation to proteins, peptides, hormones, polysaccharides, nucleic acids, liposomes, radionuclides, haptens, and toxins |
| 07/02/2002 | US6414029 Antidiabetic agents |
| 06/27/2002 | WO2002050081A2 Antimicrobial agents |
| 06/27/2002 | WO2002050046A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002024613A3 Resorcinol derivatives |
| 06/27/2002 | WO2001018171A3 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/25/2002 | US6410497 Detergents; bleaches; antiseptics |
| 06/25/2002 | US6409022 Mineral collector compositions and processes for making and using same |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020076377 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/13/2002 | WO2002046144A1 Tetralone derivatives as antitumor agents |
| 06/13/2002 | WO2002019967A3 Substituted hydrazine derivatives |
| 06/13/2002 | WO2002012220A3 Process for preparing discodermolide and analogues thereof |
| 06/13/2002 | CA2430355A1 Tetralone derivatives as antitumor agents |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | CN1353689A 新的异羟肟酸衍生物 The new hydroxamic acid derivatives |
| 06/11/2002 | US6403818 Process for producing α-hydroxy-carbonyl compound |
| 06/06/2002 | WO2002044131A1 Substituted carboxylic acid derivatives |
| 06/05/2002 | EP1210330A1 Antibacterial agents |
| 06/04/2002 | US6399776 Processes and intermediates in the synthesis of 5-(3-exo-bicyclo[2.2.1]hept-2-yloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-one |
| 06/04/2002 | US6399628 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds |
| 06/04/2002 | US6399619 Prevention and treatment of aids and viral infection by hiv |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2001092274A3 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/30/2002 | US20020065282 Tetralone derivatives |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/22/2002 | EP0966433B1 Preparation of n-aryl-n-hydroxamides |
| 05/21/2002 | US6392010 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds |
| 05/16/2002 | WO2002038596A1 Method of identifying antibacterial compounds |
| 05/16/2002 | WO2002000593A3 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 05/16/2002 | CA2431997A1 Method of identifying antibacterial compounds |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2002034260A1 6-methoxy-2-naphthylacetic acid prodrugs |
| 05/02/2002 | WO2002000609A3 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 04/27/2002 | CA2539147A1 Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 04/25/2002 | WO2001096366A3 Dipeptide inhibitors for the blood-clotting factor xa |
| 04/25/2002 | US20020049202 Administering halogenated amidino or oxyamidino compound to treat diseases caused by nitric oxide synthase |
| 04/25/2002 | US20020049185 Malonic acid based matrix metalloproteinase inhibitors |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/18/2002 | WO2002030873A1 Mmp inhibitor |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
| 04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 04/10/2002 | CN1344250A 间苯二酚衍生物 Resorcinol derivatives |
| 04/09/2002 | US6369111 Fungicides |
| 04/04/2002 | WO2002026703A1 Carbamic acid compounds comprising an ether linkage as hdac inhibitors |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | CA2423970A1 Carbamic acid compounds comprising an ether linkage as hdac inhibitors |
| 04/02/2002 | US6365637 Use of esters or amides of hydroxylated carboxylic acids as solubilizers |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | US20020038045 For therapy of diseases or conditions mediated by over-production of or over-responsiveness to Tumor necrosis factor (TNF) |